Skip to main content
HR 4825 115th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Alternative treatments Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Health personnel Licensing and registrations Medical research Research administration and funding

MEDS Act

Introduced: January 18, 2018 See on congress.gov
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 24, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jan 19, 2018
Referred to the Subcommittee on Health.
Jan 18, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 18, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Marijuana Effective Drug Studies Act of 2018 or the MEDS Act

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.

Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.

What's happening now January 24, 2018

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4825: MEDS Act. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4825/
MLA
"H.R. 4825: MEDS Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4825/.
Bluebook (legal)
H.R. 4825, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4825/.
Markdown link
[H.R. 4825: MEDS Act](https://openamerica.io/bill/115-HR-4825/)
Report a problem